Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Stylianos Kandarakis, Alexandros P. Papadopoulos, Georgios Roussopoulos, Eustathios Georgopoulos, Youngsik Chung, Leonidas Doumazos, Areum Baek, Nefeli Ioanna Paizi, Hyunik Shin & Pantelis A. Papadopoulos. (2023) COMfort Eye Trial (COMET) results - a non-inferiority, randomized, investigator-masked, two-parallel group, phase III clinical trial, to evaluate the efficacy and safety of a preservative free formulation of latanoprost versus a reference drug (Xalatan®) in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT). Expert Opinion on Drug Safety 0:0, pages 1-12.
Read now
Read now
Carl Erb, Ingeborg Stalmans, Milko Iliev & Francisco José Muñoz-Negrete. (2021) Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost. Clinical Ophthalmology 15, pages 931-938.
Read now
Read now
Sruthi Srinivasan & Venkiteshwar Manoj. (2021) A Decade of Effective Dry Eye Disease Management with Systane Ultra (Polyethylene Glycol/Propylene Glycol with Hydroxypropyl Guar) Lubricant Eye Drops. Clinical Ophthalmology 15, pages 2421-2435.
Read now
Read now
Sandra Belalcázar-Rey, Valeria Sánchez Huerta, Juan C Ochoa-Tabares, Samuel Altamirano Vallejo, Abraham Soto-Gómez, Rubén Suárez-Velasco, Filiberto García-Félix, Leopoldo Baiza-Durán, Oscar Olvera-Montaño & Patricia Muñoz-Villegas. (2021) Efficacy and Safety of Sodium Hyaluronate/chondroitin Sulfate Preservative-free Ophthalmic Solution in the Treatment of Dry Eye: A Clinical Trial. Current Eye Research 46:7, pages 919-929.
Read now
Read now
Articles from other publishers (37)
Smrithi Mani, Haoxing D. Jin, Bryce Shonka, Christopher R. Fortenbach & Jonathan F. Russell. (2023) Randomized Controlled Study of Cooled vs Room-Temperature Artificial Tears for Reducing Ocular Surface Irritation After Intravitreal Injection. Journal of VitreoRetinal Diseases 7:4, pages 310-315.
Crossref
Crossref
José Alvaro P. Gomes, Dimitri T. Azar, Christophe Baudouin, Etty Bitton, Wei Chen, Farhad Hafezi, Pedram Hamrah, Ruth E. Hogg, Jutta Horwath-Winter, Georgios A. Kontadakis, Jodhbir S. Mehta, Elisabeth M. Messmer, Victor L. Perez, David Zadok & Mark D.P. Willcox. (2023) TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface. The Ocular Surface 29, pages 331-385.
Crossref
Crossref
Lyndon Jones, Nathan Efron, Kalika Bandamwar, Melissa Barnett, Deborah S. Jacobs, Isabelle Jalbert, Heiko Pult, Michelle K. Rhee, Heather Sheardown, Joseph P. Shovlin, Ulli Stahl, Adriana Stanila, Jacqueline Tan, Silvia Tavazzi, Omur O. Ucakhan, Mark D.P. Willcox & Laura E. Downie. (2023) TFOS Lifestyle: Impact of contact lenses on the ocular surface. The Ocular Surface 29, pages 175-219.
Crossref
Crossref
Annegret Dahlmann-Noor, Stefano Bonini, Dominique Bremond-Gignac, Steffen Heegaard, Andrea Leonardi, Jesús Montero & Eduardo D. Silva. (2023) Novel Insights in the Management of Vernal Keratoconjunctivitis (VKC): European Expert Consensus Using a Modified Nominal Group Technique. Ophthalmology and Therapy 12:2, pages 1207-1222.
Crossref
Crossref
Yan Sun, Jonathan Chan, Karthikeyan Bose & Connie Tam. (2023) Simultaneous control of infection and inflammation with keratin-derived antibacterial peptides targeting TLRs and co-receptors. Science Translational Medicine 15:686.
Crossref
Crossref
John Hovanesian, I Paul Singh, Aditi Bauskar, Srilatha Vantipalli, Rabia Gurses Ozden & Michael H. Goldstein. (2023) Identifying and addressing common contributors to nonadherence with ophthalmic medical therapy. Current Opinion in Ophthalmology 34:Supplement 1, pages S1-S13.
Crossref
Crossref
Judy Weng, Michael K. Fink & Ajay Sharma. (2023) A Critical Appraisal of the Physicochemical Properties and Biological Effects of Artificial Tear Ingredients and Formulations. International Journal of Molecular Sciences 24:3, pages 2758.
Crossref
Crossref
Anne Hedengran & Miriam Kolko. (2023) Controversial preservation of eye drops: the toxicity of benzalkonium chloride. Adverse Drug Reaction Bulletin 338:1, pages 1311-1314.
Crossref
Crossref
Camilla Scarpellini, Alba Ramos Llorca, Caroline Lanthier, Greta Klejborowska & Koen Augustyns. (2023) The Potential Role of Regulated Cell Death in Dry Eye Diseases and Ocular Surface Dysfunction. International Journal of Molecular Sciences 24:1, pages 731.
Crossref
Crossref
Giulia Coco, Danilo Iannetta, Igino Febbraro, Ester Elmo & Gianluca Manni. (2022) Efficacy of Nonpreserved Sodium Hyaluronate Artificial Tears in Dry Eye Disease Patients Treated with Prostaglandin Analogs for Primary Open-Angle Glaucoma: A Prospective, Nonrandomized, Open-Label Pilot Study. Journal of Ophthalmology 2022, pages 1-8.
Crossref
Crossref
Francesco Petrillo, Arianna Petrillo, Francesca Paola Sasso, Antonietta Schettino, Angela Maione & Marilena Galdiero. (2022) Viral Infection and Antiviral Treatments in Ocular Pathologies. Microorganisms 10:11, pages 2224.
Crossref
Crossref
Tao Wang, Yunran Zhang, Meiling Chi, Chen Zhao, Linlin Cao, Chutong Tian, K. Kamei, Ying Zheng & Qikun Jiang. (2022) A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension. Asian Journal of Pharmaceutical Sciences 17:6, pages 938-948.
Crossref
Crossref
Katia Iskandar, Loïc Marchin, Laurent Kodjikian, Maxime Rocher & Christine Roques. (2022) Highlighting the Microbial Contamination of the Dropper Tip and Cap of In-Use Eye Drops, the Associated Contributory Factors, and the Risk of Infection: A Past-30-Years Literature Review. Pharmaceutics 14:10, pages 2176.
Crossref
Crossref
Sruthi Srinivasan & Ravaughn Williams. (2022) Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease. Clinical Ophthalmology Volume 16, pages 3311-3326.
Crossref
Crossref
Dipak Kumar Sahu, Deepak Pradhan, Jitu Halder, Prativa Biswasroy, Biswakanth Kar, Goutam Ghosh & Goutam Rath. (2022) Design and optimization of gatifloxacin loaded polyvinyl alcohol nanofiber for the treatment of dry eye infection: In vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology 76, pages 103651.
Crossref
Crossref
Xiaoyu Zhou, Xinyue Zhang, Dengming Zhou, Yang zhao & Xuanchu Duan. (2022) A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications. Ophthalmology and Therapy 11:5, pages 1681-1704.
Crossref
Crossref
James E. Frampton. (2022) Varenicline Solution Nasal Spray: A Review in Dry Eye Disease. Drugs 82:14, pages 1481-1488.
Crossref
Crossref
Hebatallah B. Mohamed, Basma N. Abd El-Hamid, Dina Fathalla & Ehab A Fouad. (2022) Current trends in pharmaceutical treatment of dry eye disease: A review. European Journal of Pharmaceutical Sciences 175, pages 106206.
Crossref
Crossref
Miriam Ana González-Cela-Casamayor, José Javier López-Cano, Irene Bravo-Osuna, Vanessa Andrés-Guerrero, Marta Vicario-de-la-Torre, Manuel Guzmán-Navarro, José Manuel Benítez-del-Castillo, Rocío Herrero-Vanrell & Irene Teresa Molina-Martínez. (2022) Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment. Pharmaceutics 14:7, pages 1405.
Crossref
Crossref
Julia Tau, María Silvia Passerini, Melina del Papa, Alejandro Aguilar & Alejandro Berra. (2022) A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study. Graefe's Archive for Clinical and Experimental Ophthalmology 260:6, pages 1941-1946.
Crossref
Crossref
Andrew S. Camp, Christopher P. Long, Anat Galor, Maya Yamane, James A. Proudfoot & Robert N. Weinreb. (2022) Dry Eye Symptom Severity and Visual Field Reliability Metrics. Journal of Glaucoma 31:5, pages 305-309.
Crossref
Crossref
Michael H. Goldstein, Fabiana Q. Silva, Nysha Blender, Trung Tran & Srilatha Vantipalli. (2021) Ocular benzalkonium chloride exposure: problems and solutions. Eye 36:2, pages 361-368.
Crossref
Crossref
Clizia Aversa, Giulia Cappiello & Massimiliano Barletta. (2022) Study of binary PLA/PBSA and ternary blends PLA/PCL/PBSA for the manufacturing of single dose strips. Procedia CIRP 110, pages 335-341.
Crossref
Crossref
Ruth Marrion. (2022) Optimising the medical treatment of canine corneal ulcers. Veterinary Record 190:2, pages 70-71.
Crossref
Crossref
Lech Sedlak, Marta Świerczyńska, Weronika Borymska, Maria Zych & Dorota Wyględowska-Promieńska. (2021) Impact of dorzolamide, benzalkonium-preserved dorzolamide and benzalkonium-preserved brinzolamide on selected biomarkers of oxidative stress in the tear film. BMC Ophthalmology 21:1.
Crossref
Crossref
Jo-Hsuan WuTsing-Hong WangJehn-Yu HuangChien-Chia Su. (2021) Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost. Journal of Ocular Pharmacology and Therapeutics 37:10, pages 556-564.
Crossref
Crossref
Omer Ersin Muz, Kenan Dagdelen, Tuncay Pirdal & Mete Guler. (2021) Comparison of BAK-preserved latanoprost and polyquad-preserved travoprost on ocular surface parameters in patients with glaucoma and ocular hypertension. International Ophthalmology 41:11, pages 3825-3835.
Crossref
Crossref
Q. B. Maskati, Sh. Kumar, V. Chaubey, N. Katakwar & S. Sharma. (2021) Dry eye disease and associated factors in Kazakhstan and Uzbekistan. Russian Ophthalmological Journal 14:2, pages 63-68.
Crossref
Crossref
Gloria Huerta Ángeles & Kristina Nešporová. (2021) Hyaluronan and its derivatives for ophthalmology: Recent advances and future perspectives. Carbohydrate Polymers 259, pages 117697.
Crossref
Crossref
Lyndon Jones, Alex Hui, Chau-Minh Phan, Michael L. Read, Dimitri Azar, John Buch, Joseph B. Ciolino, Shehzad A. Naroo, Brian Pall, Kathleen Romond, Padmaja Sankaridurg, Cristina M. Schnider, Louise Terry & Mark Willcox. (2021) BCLA CLEAR – Contact lens technologies of the future. Contact Lens and Anterior Eye 44:2, pages 398-430.
Crossref
Crossref
Avani Kathuria, Kiumars Shamloo, Vishal Jhanji & Ajay Sharma. (2021) Categorization of Marketed Artificial Tear Formulations Based on Their Ingredients: A Rational Approach for Their Use. Journal of Clinical Medicine 10:6, pages 1289.
Crossref
Crossref
Priyanka Agarwal, Jennifer P. Craig & Ilva D. Rupenthal. (2021) Formulation Considerations for the Management of Dry Eye Disease. Pharmaceutics 13:2, pages 207.
Crossref
Crossref
Dorota Kopacz, Łucja Niezgoda, Ewa Fudalej, Anna Nowak & Piotr Maciejewicz. 2021. Ocular Surface Diseases - Some Current Date on Tear Film Problem and Keratoconic Diagnosis. Ocular Surface Diseases - Some Current Date on Tear Film Problem and Keratoconic Diagnosis.
Nir Erdinest, Eleanor Nche, Naomi London & Abraham Solomon. (2020) Ocular allergic contact dermatitis from topical drugs. Current Opinion in Allergy & Clinical Immunology 20:5, pages 528-538.
Crossref
Crossref
Kenneth BeckmanJames KatzParag MajmudarAudrey Rostov. (2020) Loteprednol Etabonate for the Treatment of Dry Eye Disease. Journal of Ocular Pharmacology and Therapeutics 36:7, pages 497-511.
Crossref
Crossref
Anton G. Rogov, Tatyana N. Goleva, Evgeniya I. Sukhanova, Khoren K. Epremyan, Tatiana A. Trendeleva, Alexandra P. Ovchenkova, Dinara A. Aliverdieva & Renata A. Zvyagilskaya. (2020) Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride. Oxidative Medicine and Cellular Longevity 2020, pages 1-14.
Crossref
Crossref
Yongzheng Zhu, Qinyu Zhao, Hongling Jia, Hongxing Zhang & Yongchen Zhang. (2020) Acupuncture for the treatment of dry eye. Medicine 99:32, pages e21625.
Crossref
Crossref